A comprehensive evaluation of de novo metastatic breast cancer trends by subtype from the Dallas Metastatic Cancer Study | Communications Medicine

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript. Advertisement Communications Medicine volume 5, Article number: 333 (2025) Cite this article 786 Accesses Metrics details The Dallas Metastatic Cancer Study is a clinical database established to examine local trends associated with the diagnosis and treatment of de novo metastatic breast cancer and identify factors for further evaluation. Clinical characteristics of patients with de novo metastatic breast cancer are often underreported in the literature. We report data from 2010 to 2021 for patients with de novo metastatic breast cancer along with the impact of clinical variables such as age, BMI, race and ethnicity, ins

Download PDF Subjects Cancer Medical research Abstract Background The Dallas Metastatic Cancer Study is a clinical database established to examine local trends associated with the diagnosis and treatment of de novo metastatic breast cancer and identify factors for further evaluation. Clinical characteristics of patients with de novo metastatic breast cancer are often underreported in the literature. Methods We report data from 2010 to 2021 for patients with de novo metastatic breast cancer along with the impact of clinical variables such as age, BMI, race and ethnicity, insurance status, hyper

related reading

• Research advances in treatment strategies for breast cancer liver metastases: A comprehensive review - PMCpmc.ncbi.nlm.nih.gov
• Overview of the treatment of newly diagnosed, invasive, non-metastatic breast canceruptodate.com
• Association between the histopathological growth patterns of liver metastases and survival after hepatic surgery in breast cancer patients | npj Breast Cancernature.com
• Mutational interactions define novel cancer subgroupsnature.com
• Neoadjuvant immune checkpoint blockade in high-risk resectable melanomanature.com
• Comparison of the 7th and proposed 8th editions of the AJCC/UICC TNM staging system for non-small cell lung cancer undergoing radical surgerynature.com
• Epigenetic regulation during cancer transitions across 11 tumour typesnature.com
• A 50-Gene Intrinsic Subtype Classifier for Prognosis and Prediction of Benefit from Adjuvant Tamoxifen - PMCpmc.ncbi.nlm.nih.gov
• US cancer death rate drops 33% since 1991, partly due to advances in treatment, early detection and less smoking, new report says | CNNedition.cnn.com
• Real-World Effectiveness of Human Papillomavirus Vaccination Against Cervical Cancer - PMCncbi.nlm.nih.gov
• Cancer cells educate natural killer cells to a metastasis-promoting cell state - PubMedpubmed.ncbi.nlm.nih.gov
• Current and Emerging Approaches for Spine Tumor Treatmentpmc.ncbi.nlm.nih.gov